BrightSpire Capital CEO Purchased Shares Worth Over $1M

BrightSpire Capital CEO Michael Mazzei bought 309,113 shares in two transactions, totaling $1M. Prices were $3.11 and $3.28 per share on Nov 13 and 16, 2026. Mazzei now owns 1.82M shares, according to SEC filings.

Original reporting
Published Nov 17, 2026, 1:20 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 17, 2026, 1:25 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
BrightSpire Capital CEO Purchased Shares Worth Over $1M — source image
Decision brief

The 30-second read

$BRSPNeutralLow
01

Why it matters

This provides a sentiment datapoint (insider accumulation) but does not introduce new operating, financial, or strategic information that would change valuation assumptions.

02

Market read

Traders may note insider buying for sentiment, but without additional catalysts it is unlikely to materially alter the trading outlook.

03

What to watch

The article does not state whether purchases were discretionary, whether there were concurrent sales, or the CEO’s broader ownership intent, limiting interpretability.

Relevance 4/10Novelty 4/10Timing: immediately actionable as a fresh Form 4 insider purchase disclosure (Nov 13 and Nov 16 buys)

Background

The piece summarizes SEC Form 4 activity showing CEO/director Michael Mazzei purchased BrightSpire Capital shares on two dates in November 2026.

Company-level read

Ticker impact

$BRSPNeutralMedium confidence
Context

BrightSpire Capital CEO Michael Mazzei bought 80,650 shares at $3.11 and 228,463 shares at $3.28, totaling about $1.0M, per Form 4.

Expected impact

Likely limited near-term impact, with any reaction fading unless accompanied by other company-specific news.

Evidence & confidence

The article is a routine SEC Form 4 insider purchase disclosure with modest absolute size and no accompanying guidance, deal, or operational update.

Market effects

Minimal, as this is company-specific insider activity without sector-wide signal.

None indicated.

None indicated.

Counterpoint

Insider purchases can be pre-planned, tax-related, or part of compensation mechanics, so the signal may be weaker than it appears.

Key entities

  • BrightSpire Capital

    Subject of the insider purchase disclosure summarized in the article.

  • Michael Mazzei

    CEO and director who purchased shares via two Form 4 transactions.

Related articles

$BRSPMed

BrightSpire Capital Inc (BRSP) (Q3 2026) Earnings Call Highlights: Strong Loan Growth

BrightSpire Capital (BRSP) reported Q3 2026 earnings, highlighting $275M in pending loan maturities, with 80% already listed for sale. The company is diversifying into industrial, hospitality, and retail sectors, with spreads varying. CEO Mike Mazzei expects modest loan growth and plans one more CLO in 2027, aiming for a $3.5B-$3.75B loan book. The company is considering share repurchases but prioritizing liquidity.

$BRSPMed

BrightSpire (BRSP) Q3 2026 Earnings Call Transcript

BrightSpire (BRSP) reported Q3 2026 earnings, highlighting a GAAP net book value of $7.08 per share and undepreciated book value of $7.87 per share. The company noted significant volatility in capital markets, including a 10-year treasury peak of 5.37%. Despite challenges, BrightSpire achieved $272 million in originations, sold an Albertsons investment, and completed its fifth CLO. Management emphasized maintaining liquidity and balance sheet strength amidst market uncertainty.

$BRSPMed

BrightSpire Q3 2026 slides: loan growth continues, book value dips

BrightSpire Capital (NYSE:BRSP) reported Q3 2026 earnings with adjusted distributable earnings of $0.14 per share, matching expectations. Loan portfolio grew to $3.1B, but book value dipped due to credit quality pressures. Stock rose 2.02% post-report to $3.795. Management highlighted strong loan origination and asset sales, including a $300M industrial asset sale. Credit metrics showed mixed trends with increased watch list and CECL reserves.

$BRSPMed

BrightSpire Capital, Inc. Announces Third Quarter 2026 Financial Results

BrightSpire Capital, Inc. (BRSP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 BrightSpire Capital, Inc. Announces Third Quarter 2026 Financial Results NEW YORK, October 27, 2026 – BrightSpire Capital, Inc. (NYSE: BRSP) (“BrightSpire Capital” or the “Company”) today announced its financial results for the third quarter 2026 and certain updates.

$BRSPMedAI 9/10

BrightSpire Capital (BRSP) Prices $960 Million Financing Deal. Can Lending Returns Improve?

BrightSpire Capital (BRSP) priced a $960M commercial real estate CLO, set to close October 16. The deal includes 29 mortgages secured by 38 properties, with $844.8M in investment-grade securities. The weighted-average coupon is Term SOFR plus 1.54%. BRSP plans to redeem its BRSP 2024-FL2 securitization on October 19. The transaction aims to improve funding efficiency and flexibility, but risks include credit exposure and floating-rate mortgage challenges.